MedPath
NMPA Approval

Ozagrel Sodium and Sodium Chloride Injection

国药准字H20030467

July 23, 2020

Drug Information

奥扎格雷钠氯化钠注射液

泰亚普昔

泰亚普昔

注射剂

250ml:奥扎格雷钠80mg与氯化钠2.25g

化学药品

July 23, 2020

Company Information

Applicant Company

Manufacturing Company

山东省茌平县华鲁街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥扎格雷钠氯化钠注射液 - NMPA 批准文号 | MedPath